Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Beyond Air, Inc. develops and commercializes medical devices and biopharmaceutical products based on nitric oxide (NO) delivery technology. Its LungFit® platform generates NO from ambient air for respiratory treatments, including FDA-approved therapy for persistent pulmonary hypertension of the newborn (PPHN) and investigational uses in lung infections and chronic pulmonary diseases. The company targets hospitals and healthcare providers with innovative, portable NO delivery systems offering antimicrobial and vasodilatory benefits.
This description was generated via AI from an annual report. Updated about 1 year ago.